Therapeutic Advances in Urology

Editor: Anthony Atala Wake Forest University, USA
Associate Editor: Francois Alexandre Giuliano Raymond Poincare Hospital, France
Göran Läckgren University Childrens Hospital, Uppsala, Sweden
Alan Partin Johns Hopkins University School of Medicine, USA
Jean de la Rosette AMC University Hospital, The Netherlands
Peter N Schlegel Weill Cornell Medical College, USA
Alan Wein University of Pennsylvania, USA
Managing Editor: Matthew Thorne SAGE Publications, UK
Assistant Editor: Karim Kader Wake Forest University School of Medicine, Winston-Salem, USA
Manuscript Submission Guidelines:

Therapeutic Advances in Urology

 

Instructions for Authors (online version)

Correspondence and online submission

Publication categories

Writing your manuscript

Reference Formatting

Research Ethics

Publication statement

Peer review statement

Journal Contributor's Publishing Agreement

Declaration of Conflicting Interests Policy

Authorship

Informed Consent

Permissions

 

Correspondence and online submission

All correspondence, including notification of the Editor's decision and requests for revisions, will be by e-mail. All manuscript submissions should be made online at the Therapeutic Advances in Urology SAGEtrack website: http://mc.manuscriptcentral.com/tau



 - If you have not used the site before, please click the 'Create Account' link and follow the on-screen instructions.

 - If you have previously used the Therapeutic Advances in Urology site, either as an author or a referee, please use your existing login details. If you do not know your login details, simply enter your email address in the 'Forgot your password' box and you will receive instructions on how to log in right away.


Once you have logged in to the site, please select 'Author Center', then 'Click here to submit a manuscript'.


Publication categories

The Journal considers the following kinds of article for publication:

1. Research Reports, describing new experimental findings;

2. Review Articles. The Editors wish to encourage the following types of review, but request that authors contact them in advance:

(a) general reviews that provide a synthesis of an area of musculoskeletal disease;

(b) perspectives - brief overviews, which are 6-8 printed pages in length including references, that address important new areas of general interest;

(c) critiques - focused and provocative reviews that are followed by a number of invited commentaries, with a concluding reply from the main author;

(d) structured case reports - outlining an interesting case, including a section on implications for clinical care (prevention, recognition and management);

3. Letters to the Editor

These should be as concise as possible and never exceed 500 words.

 

Writing your manuscript

Therapeutic Advances in Urology subscribes predominantly to the editorial preferences expressed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals [ICMJE, 2007] issued by the International Committee of Medical Journal Editors. Each page should be numbered and identified with a shortened version of the title.


Abstract - The abstract should accurately and concisely reflect the content of the article. Original research articles should include structured abstracts, using the four headings Objectives, Methods, Results, and Conclusions. Please avoid reference citations and undefined abbreviations in the abstract.

Key words (or key word phrases) 2-8 to accompany the abstract. They should, if possible, be drawn from the MeSH list of Index Medicus and be chosen with a view to useful cross-indexing of the article.


Main text - Subdivide your article with appropriate headings. Use no more than two levels of subheading.


Acknowledgements - Between the end of the main text and the start of the references section, please acknowledge sources of financial and material support, and those who have contributed intellectually, with their consent.


Tables must all be cited in the text, carry brief but complete titles, and be numbered consecutively with Arabic numerals. Keep rules (horizontal only) to a minimum.

Figures should be supplied as vector-based, separate .eps files (not as .tiff files, and not only inserted in the Word or pdf file), with a resolution of 300dpi (dots per inch). They should be used with discretion to clarify (not duplicate) the text. They should be cited in the text, using arabic numerals, and their approximate location in the paper clearly indicated [Figure 1 near here]. They should, for preference, be supplied at reproduction size (single- or double-column width), and lettering should be no smaller than 8pt type.

Legends should be explanatory but succinct. They should carry the arabic numerals applicable to the figures, and be provided as a separate typed list at the end of the paper, along with the figures themselves.


Units of measurement should be expressed in SI and metric units; older conventional units may be added in parentheses.
Nomenclature: Use the generic or chemical name of any drug, in lower case; the specific trade name (capitalized) may be given in parentheses after the first text reference.

Standard Abbreviations and symbols should be used, then defined in full in the first instance unless they are standard units of measurement. Avoid any use of abbreviations in the article title and abstract.

 

Reference Formatting

EndNote Users: Click here to download the journal's style file (.ens).

Reference Manager Users: Click here to download the journal's style file (.os).

In the main text, place each author in square parentheses, throughout the text, tables, and legends: [Author A, 2004]; [Author A and Author B, 2006]; [Author et al. 2007]


In the reference list, all references appear alphabetically. Please list up to 6 authors, or 6 authors followed by et al

Authors: List each author's last name and initials; full first names are not included. For books with chapters written by individual authors, list the authors of the chapter first, then the chapter title, followed by 'In', the editors' names, and the book title, the publisher, and the location.

Book titles, chapter titles: Capitalize the first letter of the first word in the title. The rest of the title is in lower-case, with the exception of proper names (see example 3 below). Do not underline the title; do not use italics.


Example - Journal citations


Abduljawad, K.A.J. and Langley, R.W. (2001) Article title here. J Psychopharmacol 15: 237-242.

Smith, H., Miller, M., Agarwal, S., Sinetti, M., Yan, C., Long, T. et al. (2000) Article title here. J Psychopharmacol 15: 237-242.


Example - Book citations


Lader, M. (1977) Effects of psychotropic drugs on auditory evoked potentials in man. In Desmedt, J.E. (ed), Auditory evoked potentials in man: psychopharmacology correlates of evoked potentials, Karger: Basel.

 

Research Ethics

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Declaration of Helsinki 1975, revised Hong Kong 1989. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or the National Research Council's guide for, or any national law on, the care and use of laboratory animals was followed.

 

Publication statement

Papers submitted to this Journal for publication are considered on condition that they have been neither submitted elsewhere, nor published elsewhere other than in abstract form. The Editors do not enter into correspondence about papers considered unsuitable for publication; their decision is final. Requirements for publication in the Journal are in accordance with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals [ICMJE, 2007].

 

Peer review statement

Therapeutic Advances in Urology adheres to a blinded peer review process in which the reviewers' names are routinely withheld from the author unless a reviewer requests a preference for his or her identity to be revealed. Authors are invited to suggest the names, affiliations and contact information of up to six individuals who may be suitable to serve as referees, but the Editors are under no obligation to use all or any of these individuals as reviewers. All manuscripts are reviewed initially by the Editors and only those papers that meet the scientific and editorial standards of the journal, and fit within the aims and scope of the journal, will be sent for outside review. Each research article and review manuscript is reviewed by at least two referees. All manuscripts are reviewed as rapidly as possible, and a first editorial decision is generally reached within 3 weeks of submission.

 

Journal Contributor's Publishing Agreement

Before publication SAGE requires the author as the rights holder to sign a Journal Contributor's Publishing Agreement. SAGE's Journal Contributor's Publishing Agreement is a exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway (http:/www.uk.sagepub.com/journalEditors.nav).



Declaration of Conflicting Interests Policy

Within your Journal Contributor's Publishing Agreement you will be required to make a certification with respect to a declaration of conflicting interests. It is the policy of Therapeutic Advances in Urology to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please include a declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading 'Conflict of Interest Statement'. If no declaration is made the following will be printed under this heading in your article: 'None Declared'. Alternatively, you may wish to state that 'The Author(s) declare(s) that there is no conflict of interest'. When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article. Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Conflict of Interest statement provided in the article. For more information please visit the SAGE Journal Author Gateway (http:/www.uk.sagepub.com/journalEditors.nav).



Authorship

Authors should declare whether or not they had assistance with study design, data collection, data analysis, or manuscript preparation. If such assistance was available, the authors should disclose the identity of the people that provided this assistance and the entity that supported it in the published article. Financial and material support should also be acknowledged.



Informed Consent

Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

When informed consent has been obtained it should be indicated in the submitted article.


Permissions

Authors must obtain written permission from the copyright holder (original author or publisher) to include in their paper any previously published material. Credit should follow the style and location requested by the copyright holder.



On Publication

Access to 25 free e-prints will be provided; the corresponding author will receive five complimentary copies of the journal.


 

References

International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication http:/www.icmje.org/. Updated October 2007. Retrieved April 2008

Subscription Information:
Institutional Subscription, Combined (Print & E-access) $1,019.00
Institutional Subscription, E-access $917.00
Institutional Subscription, Print Only $999.00
Individual Subscription, Print Only $137.00

Individual articles are available for immediate purchase online (See View Full-Text icon above). Print copies of individual issues can be purchased by contacting the SAGE Journals Customer Service department journals@sagepub.com 1-800-818-7243.

If you are eligible for non-standard pricing please contact Journals Customer Service department journals@sagepub.com 1-800-818-7243 for a price quote.

Institutional, Single Print Issue $183.00
Individual, Single Print Issue $30.00
Frequency: Bi-monthly eISSN: 1756-2880 ISSN: 1756-2872
Months of Distribution: February , April , June , August , October , December Current Volume: 1 Current Issue: 5
Other Titles In: Clinical Medicine